| Autor: |
Miłek T; First Department of General and Vascular Surgery, Second Faculty of Medicine, Warsaw Medical University, Warsaw, Poland., Nagraba Ł; Department of Orthopedics and Rehabilitation, Warsaw Medical University, Warsaw, Poland., Mitek T; Department of Orthopedics and Rehabilitation, Warsaw Medical University, Warsaw, Poland., Woźniak W; First Department of General and Vascular Surgery, Second Faculty of Medicine, Warsaw Medical University, Warsaw, Poland., Mlosek K; Department of Imaging Examinations, Warsaw Medical University, Warsaw, Poland., Olszewski W; Division of Pathology and Laboratory Diagnostics, The Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland., Ciostek P; First Department of General and Vascular Surgery, Second Faculty of Medicine, Warsaw Medical University, Warsaw, Poland., Deszczyński J; Department of Orthopedics and Rehabilitation, Warsaw Medical University, Warsaw, Poland., Kuchar E; Department of Pediatrics with Clinical Assessment Unit, Warsaw Medical University, Warsaw, Poland. ernest.kuchar@wum.edu.pl., Stolarczyk A; Department of Imaging Examinations, Warsaw Medical University, Warsaw, Poland. |
| Abstrakt: |
The study investigated whether the application of dressings with autologous platelet-rich plasma (PRP) would reduce the healing time in patients with chronic venous leg ulcers. This is a prospective observational study that included 100 patients diagnosed with lower extremity venous insufficiency complicated by ulceration of a leg or foot, who had been after angioplasty of stenotic artery. Patients were divided into two groups of 50 each: treated with PRP (study group) and treated with conventional hydrocolloid dressings (control group). We followed the wound changes at Day 10, Day 20, and Day 30 of treatment and compared them with the baseline appearance at Day 0. We evaluated the appearance, area, and depths of wounds with ultrasound. The granulation process was examined histologically to document skin formation and wound tissue neovascularization. The findings were that treatment with PRP dressings resulted in a significant progressive reduction in ulcer size, irrespective of the ulcer's initial size, compared to treatment with conventional dressings. Further, the best effect of PRP was noticed in the category of largest wounds. After a month of treatment with PRP dressings, more than 50% of all ulcers were completely healed. The young epidermis appeared together with the granulation tissue, and the formation of dermis took shape after 20 days of treatment. We conclude that the use of PRP dressings is a safe, nonsurgical adjunctive procedure for treating chronic venous leg ulcers. The potential benefit of PRP dressings over conventional ulcer treatment requires further in-depth exploration. |
